Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Lacrimal Gland Tumor

This section has been reviewed and approved by the Cancer.Net Editorial Board, 5/2012

In general, a lacrimal gland tumor is rare. About half of lacrimal gland tumors are benign, and half are malignant. Malignant epithelial tumors of the lacrimal gland account for 2% of all orbital (eye socket) tumors. AdCC is the most frequent epithelial orbital cancer, accounting for approximately 50% of malignant lacrimal gland tumors and 25% of all lacrimal gland tumors.

Survival rates depend on several factors, including the type and subtype of lacrimal gland tumor. The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. The five-year survival rate of people with AdCC is estimated to be 50%, while the 15-year survival rate is estimated to be 25%.

Cancer survival statistics should be interpreted with caution. It is not possible to tell a person how long he or she will live with a lacrimal gland tumor. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of a lacrimal gland tumor. Learn more about understanding statistics.

Source: DeAngelis, Dan, MD, FRCS, "Lacrimal Gland Tumors," http://reference.medscape.com/article/1210619-overview. Updated August 2, 2013.

Last Updated: 
Thursday, February 27, 2014

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: